|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
Director |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
537,854 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,021,652 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
785,387 |
|
|
Total
Value |
$64,960,502 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-34.0%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
Director |
2023-11-07 |
7,615 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
851 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NGSX |
Neurogesx Inc |
Director |
|
2008-12-08 |
4 |
B |
$1.51 |
$1,165 |
D/D |
700 |
32,422 |
2.31 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2021-12-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
700 |
303,689 |
0 |
- |
|
PTLA |
Portola Pharmaceuticals I... |
Director |
|
2013-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
706 |
706 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2011-05-31 |
4 |
AS |
$28.00 |
$19,880 |
D/D |
(710) |
129,093 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2014-04-30 |
4 |
A |
$29.69 |
$21,228 |
D/D |
715 |
195,235 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-10-01 |
4 |
OE |
$6.46 |
$5,123 |
D/D |
793 |
26,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-10-01 |
4 |
AS |
$25.10 |
$19,904 |
D/D |
(793) |
6,695 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2020-11-10 |
4 |
S |
$83.00 |
$66,234 |
D/D |
(798) |
8,646 |
0 |
% |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-02-26 |
4 |
B |
$20.08 |
$16,062 |
D/D |
800 |
48,740 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-10 |
4 |
AS |
$67.48 |
$53,985 |
D/D |
(800) |
111,038 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-04-30 |
4 |
A |
$51.26 |
$46,547 |
D/D |
908 |
252,159 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-04-30 |
4 |
A |
$23.21 |
$21,256 |
D/D |
916 |
120,317 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-03-04 |
4 |
AS |
$107.71 |
$98,660 |
I/I |
(916) |
42,279 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
officerTitle |
|
2005-12-12 |
4 |
B |
$10.21 |
$10,208 |
D/D |
1,000 |
11,000 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-05-08 |
4 |
B |
$12.78 |
$12,778 |
D/D |
1,000 |
22,881 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-05-18 |
4 |
B |
$12.00 |
$12,000 |
D/D |
1,000 |
23,881 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-02-22 |
4 |
AS |
$18.40 |
$18,400 |
D/D |
(1,000) |
19,642 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2009-03-05 |
4/A |
B |
$10.04 |
$10,039 |
D/D |
1,000 |
11,917 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2009-03-05 |
4 |
A |
$10.04 |
$10,039 |
D/D |
1,000 |
11,917 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-09-02 |
4 |
AS |
$20.89 |
$20,890 |
D/D |
(1,000) |
95,067 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-09-08 |
4 |
OE |
$6.46 |
$6,460 |
D/D |
1,000 |
96,067 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-09-08 |
4 |
S |
$22.22 |
$22,220 |
D/D |
(1,000) |
95,067 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-11-18 |
4 |
OE |
$6.46 |
$6,460 |
D/D |
1,000 |
94,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-11-18 |
4 |
S |
$25.99 |
$25,988 |
D/D |
(1,000) |
93,567 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2010-11-23 |
4 |
OE |
$6.46 |
$6,460 |
D/D |
1,000 |
94,567 |
0 |
- |
|
851 Records found
|
|
Page 4 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|